These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30877412)

  • 1. Cell membrane protein functionalization of nanoparticles as a new tumor-targeting strategy.
    Pasto A; Giordano F; Evangelopoulos M; Amadori A; Tasciotti E
    Clin Transl Med; 2019 Mar; 8(1):8. PubMed ID: 30877412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell membrane biomimetic nanoparticles for inflammation and cancer targeting in drug delivery.
    Wang H; Liu Y; He R; Xu D; Zang J; Weeranoppanant N; Dong H; Li Y
    Biomater Sci; 2020 Jan; 8(2):552-568. PubMed ID: 31769765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell Membrane-Camouflaged Nanoparticles: A Promising Biomimetic Strategy for Cancer Theragnostics.
    Vijayan V; Uthaman S; Park IK
    Polymers (Basel); 2018 Sep; 10(9):. PubMed ID: 30960908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends towards Biomimicry in Theranostics.
    Evangelopoulos M; Parodi A; Martinez JO; Tasciotti E
    Nanomaterials (Basel); 2018 Aug; 8(9):. PubMed ID: 30134564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticles disguised as red blood cells to evade the immune system.
    Fang RH; Hu CM; Zhang L
    Expert Opin Biol Ther; 2012 Apr; 12(4):385-9. PubMed ID: 22332936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell membrane coated nanoparticles: next-generation therapeutics.
    Narain A; Asawa S; Chhabria V; Patil-Sen Y
    Nanomedicine (Lond); 2017 Nov; 12(21):2677-2692. PubMed ID: 28965474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem-Cell-Membrane Camouflaging on Near-Infrared Photoactivated Upconversion Nanoarchitectures for in Vivo Remote-Controlled Photodynamic Therapy.
    Gao C; Lin Z; Wu Z; Lin X; He Q
    ACS Appl Mater Interfaces; 2016 Dec; 8(50):34252-34260. PubMed ID: 27936561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coating nanoparticles with cell membranes for targeted drug delivery.
    Gao W; Zhang L
    J Drug Target; 2015; 23(7-8):619-26. PubMed ID: 26453159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell Membrane Coated Nanoparticles: An Emerging Biomimetic Nanoplatform for Targeted Bioimaging and Therapy.
    Vijayan V; Uthaman S; Park IK
    Adv Exp Med Biol; 2018; 1064():45-59. PubMed ID: 30471025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface Functionalization of Polymeric Nanoparticles with Umbilical Cord-Derived Mesenchymal Stem Cell Membrane for Tumor-Targeted Therapy.
    Yang N; Ding Y; Zhang Y; Wang B; Zhao X; Cheng K; Huang Y; Taleb M; Zhao J; Dong WF; Zhang L; Nie G
    ACS Appl Mater Interfaces; 2018 Jul; 10(27):22963-22973. PubMed ID: 29905067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomimetic and bioinspired nanoparticles for targeted drug delivery.
    Gagliardi M
    Ther Deliv; 2017 Mar; 8(5):289-299. PubMed ID: 28361608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research update on cell membrane camouflaged nanoparticles for cancer therapy.
    Wang C; Wu S
    Front Bioeng Biotechnol; 2022; 10():944518. PubMed ID: 35992357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomimetic Nanocarriers for Cancer Target Therapy.
    Guido C; Maiorano G; Cortese B; D'Amone S; Palamà IE
    Bioengineering (Basel); 2020 Sep; 7(3):. PubMed ID: 32937963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing Inflammation Targeting Using Tunable Leukocyte-Based Biomimetic Nanoparticles.
    Zinger A; Sushnitha M; Naoi T; Baudo G; De Rosa E; Chang J; Tasciotti E; Taraballi F
    ACS Nano; 2021 Apr; 15(4):6326-6339. PubMed ID: 33724785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in targeted nanotherapeutics: From bioconjugation to biomimicry.
    Valcourt DM; Harris J; Riley RS; Dang M; Wang J; Day ES
    Nano Res; 2018 Oct; 11(10):4999-5016. PubMed ID: 31772723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic Profiling of a Biomimetic Drug Delivery Platform.
    Corbo C; Parodi A; Evangelopoulos M; Engler DA; Matsunami RK; Engler AC; Molinaro R; Scaria S; Salvatore F; Tasciotti E
    Curr Drug Targets; 2015; 16(13):1540-7. PubMed ID: 25382209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell source determines the immunological impact of biomimetic nanoparticles.
    Evangelopoulos M; Parodi A; Martinez JO; Yazdi IK; Cevenini A; van de Ven AL; Quattrocchi N; Boada C; Taghipour N; Corbo C; Brown BS; Scaria S; Liu X; Ferrari M; Tasciotti E
    Biomaterials; 2016 Mar; 82():168-77. PubMed ID: 26761780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bio-inspired engineering of cell- and virus-like nanoparticles for drug delivery.
    Parodi A; Molinaro R; Sushnitha M; Evangelopoulos M; Martinez JO; Arrighetti N; Corbo C; Tasciotti E
    Biomaterials; 2017 Dec; 147():155-168. PubMed ID: 28946131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Starvation-amplified CO generation for enhanced cancer therapy via an erythrocyte membrane-biomimetic gas nanofactory.
    Wang Y; Liu Z; Wang H; Meng Z; Wang Y; Miao W; Li X; Ren H
    Acta Biomater; 2019 Jul; 92():241-253. PubMed ID: 31078766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxygen self-enriched nanoparticles functionalized with erythrocyte membranes for long circulation and enhanced phototherapy.
    Ren H; Liu J; Li Y; Wang H; Ge S; Yuan A; Hu Y; Wu J
    Acta Biomater; 2017 Sep; 59():269-282. PubMed ID: 28663143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.